Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 23, 2022 16:01 ET | Source: TELA Bio, Inc.

TELA Bio to Participate in Inaugural Gilmartin Group Emerging Growth Company Showcase

MALVERN, Pa., Aug. 23, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that...
August 18, 2022 16:01 ET | Source: TELA Bio, Inc.

TELA Bio Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriter’s Option to Purchase Additional Shares

MALVERN, Pa., Aug. 18, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that...
August 15, 2022 22:20 ET | Source: TELA Bio, Inc.

TELA Bio Announces Pricing of Public Offering of Common Stock

MALVERN, Pa., Aug. 15, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that...
August 15, 2022 16:01 ET | Source: TELA Bio, Inc.

TELA Bio Announces Proposed Public Offering of Common Stock

MALVERN, Pa., Aug. 15, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that...
August 10, 2022 16:01 ET | Source: TELA Bio, Inc.

TELA Bio Reports Second Quarter 2022 Financial Results

MALVERN, Pa., Aug. 10, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that...
August 05, 2022 07:00 ET | Source: TELA Bio, Inc.

TELA Bio to Participate in Upcoming Investor Conferences

MALVERN, Pa., Aug. 05, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that...
August 04, 2022 07:00 ET | Source: TELA Bio, Inc.

TELA Bio Highlights Results from BRAVO and ReBAR Studies on the Benefits of OviTex® Reinforced Tissue Matrix in Hernia Repairs; Data to Be Presented at 2022 American Hernia Society (AHS) Meeting

24-Month BRAVO study results showed a 2.6% recurrence rate in diverse clinical scenarios Robotic Reinforced Biologic Augmented Repair (ReBAR) study showed a 1.9% recurrence rate at two-year mark ...
July 29, 2022 16:01 ET | Source: TELA Bio, Inc.

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., July 29, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction...
July 27, 2022 07:00 ET | Source: TELA Bio, Inc.

TELA Bio to Announce Second Quarter 2022 Financial Results

MALVERN, Pa., July 27, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that...
July 20, 2022 07:00 ET | Source: TELA Bio, Inc.

TELA Bio Awarded Synthetic Bioabsorbable Mesh Products Agreement with Premier, Inc.

MALVERN, Pa., July 20, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA”), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that...